Glaucoside C

Details

Top
Internal ID 7e877280-fa9f-4b8a-9396-106d12d8317f
Taxonomy Organic oxygen compounds > Organooxygen compounds > Carbohydrates and carbohydrate conjugates > Oligosaccharides
IUPAC Name (4S,5R,7R,8R,13R,16S,19R,22R)-7-hydroxy-8-[(2S,4S,5R,6R)-5-[(2S,4S,5S,6R)-4-hydroxy-5-[(2S,4R,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5,19-dimethyl-15,18,20-trioxapentacyclo[14.5.1.04,13.05,10.019,22]docosa-1(21),10-dien-14-one
SMILES (Canonical) CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3OC)OC4CC5=CCC6C(C5(CC4O)C)CCC7=COC8(C7C(CO8)OC6=O)C)C)C)OC)O
SMILES (Isomeric) C[C@H]1[C@@H]([C@@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3OC)O[C@@H]4CC5=CC[C@@H]6[C@@H]([C@]5(C[C@H]4O)C)CCC7=CO[C@@]8([C@H]7[C@@H](CO8)OC6=O)C)C)C)OC)O
InChI InChI=1S/C41H62O15/c1-19-36(44)29(46-6)14-34(50-19)55-37-20(2)51-32(13-26(37)42)56-38-21(3)52-33(15-30(38)47-7)53-28-12-23-9-10-24-25(40(23,4)16-27(28)43)11-8-22-17-48-41(5)35(22)31(18-49-41)54-39(24)45/h9,17,19-21,24-38,42-44H,8,10-16,18H2,1-7H3/t19-,20+,21+,24+,25-,26-,27+,28+,29+,30-,31+,32-,33-,34-,35+,36-,37+,38+,40-,41-/m0/s1
InChI Key BRAQGYOYQRQKSH-DVDJMWJGSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C41H62O15
Molecular Weight 794.90 g/mol
Exact Mass 794.40887127 g/mol
Topological Polar Surface Area (TPSA) 179.00 Ų
XlogP 1.80
Atomic LogP (AlogP) 3.00
H-Bond Acceptor 15
H-Bond Donor 3
Rotatable Bonds 8

Synonyms

Top
Cynanoside J

2D Structure

Top
2D Structure of Glaucoside C

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9872 98.72%
Caco-2 - 0.8712 87.12%
Blood Brain Barrier - 0.6500 65.00%
Human oral bioavailability - 0.7000 70.00%
Subcellular localzation Mitochondria 0.8323 83.23%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8415 84.15%
OATP1B3 inhibitior + 0.9719 97.19%
MATE1 inhibitior - 0.9600 96.00%
OCT2 inhibitior - 0.7500 75.00%
BSEP inhibitior + 0.9435 94.35%
P-glycoprotein inhibitior + 0.7470 74.70%
P-glycoprotein substrate + 0.7598 75.98%
CYP3A4 substrate + 0.7369 73.69%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8858 88.58%
CYP3A4 inhibition - 0.8476 84.76%
CYP2C9 inhibition - 0.9148 91.48%
CYP2C19 inhibition - 0.9613 96.13%
CYP2D6 inhibition - 0.9445 94.45%
CYP1A2 inhibition - 0.8823 88.23%
CYP2C8 inhibition + 0.5975 59.75%
CYP inhibitory promiscuity - 0.9502 95.02%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 0.9800 98.00%
Carcinogenicity (trinary) Non-required 0.4604 46.04%
Eye corrosion - 0.9902 99.02%
Eye irritation - 0.9167 91.67%
Skin irritation + 0.5000 50.00%
Skin corrosion - 0.9385 93.85%
Ames mutagenesis - 0.6400 64.00%
Human Ether-a-go-go-Related Gene inhibition + 0.6906 69.06%
Micronuclear - 0.7900 79.00%
Hepatotoxicity + 0.5323 53.23%
skin sensitisation - 0.8945 89.45%
Respiratory toxicity + 0.8000 80.00%
Reproductive toxicity + 0.9556 95.56%
Mitochondrial toxicity + 0.7000 70.00%
Nephrotoxicity - 0.5817 58.17%
Acute Oral Toxicity (c) I 0.5334 53.34%
Estrogen receptor binding + 0.8161 81.61%
Androgen receptor binding + 0.7221 72.21%
Thyroid receptor binding - 0.5328 53.28%
Glucocorticoid receptor binding + 0.7551 75.51%
Aromatase binding + 0.6654 66.54%
PPAR gamma + 0.7616 76.16%
Honey bee toxicity - 0.6048 60.48%
Biodegradation - 0.7250 72.50%
Crustacea aquatic toxicity + 0.6200 62.00%
Fish aquatic toxicity + 0.9456 94.56%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 98.85% 85.14%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.32% 91.11%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 97.55% 96.09%
CHEMBL1994 P08235 Mineralocorticoid receptor 92.67% 100.00%
CHEMBL1806 P11388 DNA topoisomerase II alpha 92.06% 89.00%
CHEMBL3137262 O60341 LSD1/CoREST complex 91.17% 97.09%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 90.43% 94.45%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 89.15% 99.23%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 88.86% 95.89%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 88.10% 95.56%
CHEMBL4303 P08238 Heat shock protein HSP 90-beta 86.78% 96.77%
CHEMBL4478 Q00975 Voltage-gated N-type calcium channel alpha-1B subunit 86.66% 97.14%
CHEMBL2581 P07339 Cathepsin D 86.40% 98.95%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 86.26% 94.00%
CHEMBL1914 P06276 Butyrylcholinesterase 86.04% 95.00%
CHEMBL3713062 P10646 Tissue factor pathway inhibitor 85.99% 97.33%
CHEMBL5608 Q16288 NT-3 growth factor receptor 85.97% 95.89%
CHEMBL253 P34972 Cannabinoid CB2 receptor 85.55% 97.25%
CHEMBL5255 O00206 Toll-like receptor 4 85.48% 92.50%
CHEMBL3091268 Q92753 Nuclear receptor ROR-beta 85.05% 95.50%
CHEMBL2373 P21730 C5a anaphylatoxin chemotactic receptor 83.64% 92.62%
CHEMBL4051 P13569 Cystic fibrosis transmembrane conductance regulator 81.39% 95.71%

Cross-Links

Top
PubChem 11764253
NPASS NPC290015
LOTUS LTS0023611
wikiData Q104944667